MELISSA HOYT: Open Payments
NPI 1649917725 · SARATOGA SPRINGS, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 28 payments from 15 companies in 2025. Trend: 2023 $34 · 2024 $158 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $158 |
| Janssen Pharmaceuticals, Inc | 2 | $116 |
| E.R. Squibb & Sons, L.L.C. | 1 | $93 |
| ABBVIE INC. | 3 | $63 |
| Lilly USA, LLC | 3 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Corium, LLC | 5 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
Products named: AUSTEDO XR, SPRAVATO, COBENFY, INGREZZA, VRAYLAR, MOUNJARO, Azstarys, UBRELVY.
Industry payments across UT — which companies pay providers there.
